Gerresheimer's €10 Million Insider Bet Rides on a June Audit Deliverable

Activist investor Active Ownership buys €10M in Gerresheimer shares, betting on audited 2025 report due June to restore creditor confidence and lift stock from lows.

The fate of Gerresheimer’s turnaround story hinges on a single document due in June. While the packaging specialist’s largest shareholder has loaded up on almost €10 million worth of stock, the company must first deliver its audited annual report for 2025 — a milestone that will determine whether creditors extend their patience and investors regain confidence.

Active Ownership, the activist investor behind AOC Gecko, snapped up roughly 287,000 shares in three tranches during the first week of May. The average purchase price came in at around €25 each, pushing the group’s total stake comfortably above the 15% threshold. The buying spree currently tops Germany’s list of notifiable securities transactions, marking a clear vote of confidence from an insider who knows the balance sheet intimately.

Yet the timing is anything but serene. Gerresheimer stunned markets late last year when it admitted to booking revenue from bill-and-hold contracts years before the goods were actually shipped. The accounting errors — totalling €35 million in misstatements for fiscal 2024 alone — sit at the centre of probes by both the German financial regulator BaFin and the audit oversight body APAS. The latter has also opened proceedings against KPMG, which issued an unqualified opinion on those flawed 2024 accounts.

The clean-up has proved costly. The company now expects non-cash impairments of up to €240 million for the past financial year, largely tied to Sensile Medical projects and its Chicago Heights facility, which is slated to close by the end of 2026. Those write-downs ate into equity and pushed leverage to uncomfortable levels, forcing management to negotiate with creditors.

Lenders have bought time, but only just. Banks and Schuldschein noteholders extended the deadline for audited 2025 financials until September 2026 and temporarily waived certain debt covenants. The goal is to sell the US subsidiary Centor before year-end — several interested parties are already reviewing the books, according to the company. Proceeds would slash the debt burden and restore breathing room.

Operationally, the picture holds up better. Gerresheimer continues to target full-year revenue of up to €2.4 billion and an adjusted operating margin of roughly 18%. Management stuck to that guidance even as the accounting storm raged.

The stock market has been a rollercoaster. After hitting a 52-week low, shares have rebounded sharply — up about 43% over the past month — as short sellers began covering their positions. The insider buying accelerated the squeeze. Yet the rally lost momentum on Thursday, with the stock slipping 4.5% to close at €25.20 in Frankfurt, still a far cry from the old high above €64.

A concrete date for the annual general meeting has yet to be set. In June, Gerresheimer aims to unveil the audited 2025 financials together with first-quarter figures. If the company delivers on time, investors will finally have a reliable data set to assess the recovery. A second key check-point follows on 14 July, when the half-year report is due. Until then, the €10 million insider wager remains a bet on whether the June testat can clear the air.